Clinical trials recruiting for Pancreatic Adenocarcinoma Metastatic
6
Recruiting trials
25
US states with sites
7
Countries
0%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Nab-paclitaxel | 2 |
| 5-Fluorouracil | 1 |
| Atebimetinib | 1 |
| BCNU | 1 |
| FOLFIRI | 1 |
| Gemcitabine | 1 |
| Gemcitabine (GEM) | 1 |
| GnP | 1 |
| Ipilimumab | 1 |
| Irinotecan | 1 |
| Leucovorin (Calcium Folinate) | 1 |
| Melphalan | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Arizona | 3 |
| Florida | 3 |
| Maryland | 3 |
| Massachusetts | 3 |
| New York | 3 |
| California | 2 |
| Georgia | 2 |
| Illinois | 2 |
| Nevada | 2 |
| New Jersey | 2 |
| Ohio | 2 |
| Pennsylvania | 2 |
Top cities
Boston, Massachusetts 3New York, New York 3Atlanta, Georgia 2Baltimore, Maryland 2Chicago, Illinois 2Fairfax, Virginia 2Maumee, Ohio 2Nashville, Tennessee 2Philadelphia, Pennsylvania 2Seattle, Washington 2
Self-screener
Recruiting trials
- Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Maintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy
- SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells
- Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
- TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC)
Related conditions
Trials recruiting for Pancreatic Adenocarcinoma Metastatic often also study these conditions. Each links to its own recruiting-trial list.
Pancreatic cancer 870PDAC - Pancreatic Ductal Adenocarcinoma 21PDAC 11Pancreatic Ductal Adenocarcinoma (PDAC) 32Pancreatic Ductal Adenocarcinoma 64Pancreatic Cancer Metastatic 16Pancreatic Adenocarcinoma 49Pancreatic Adenosquamous Carcinoma 4Pancreatic Cancer Stage IV 5Pancreas Cancer, Metastatic 4
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Pancreatic Adenocarcinoma Metastatic trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.